CMG PHARMACEUTICAL CO LTD has a total of 18 patent applications. Its first patent ever was published in 2013. It filed its patents most often in Republic of Korea, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are OPKO HEALTH INC, RVX THERAPEUTICS INC and VERTEKS FARMASYUTIKALZ INKORPOREJTED.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 4 | |
#2 | United States | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Australia | 1 | |
#6 | Brazil | 1 | |
#7 | China | 1 | |
#8 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Heterocyclic compounds | |
#3 | Therapeutic chemical compounds | |
#4 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Lee Gilnam | 7 |
#2 | Seo Jeongbeob | 7 |
#3 | Lee Minwoo | 6 |
#4 | Kim Moonsoo | 6 |
#5 | Kim Misoon | 6 |
#6 | Choi Soongyu | 6 |
#7 | Lee Jae Il | 6 |
#8 | Kim Hyun Jung | 6 |
#9 | Kim Hye Kyoung | 6 |
#10 | Choi Hyang | 6 |
Publication | Filing date | Title |
---|---|---|
US2019292150A1 | Ido-tdo dual inhibitor and related methods of use | |
CN107207514A | Fused ring heteroaryl compound and its purposes as TRK inhibitor | |
KR20160139704A | Formulation for orodispersible film comprising aripirazole, and method of preparing the same | |
US2015158874A1 | Pyridopyrimidine derivatives and use thereof | |
KR20130121071A | Formulation for orodispersible film comprising rosuvastatin | |
EP2828258A1 | Novelpyridopyrimidine derivatives and use thereof |